Mowery & Schoenfeld Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67K Sell
10
-6
-38% -$1.63K ﹤0.01% 309
2025
Q4
$4.01K Buy
16
+6
+60% +$1.59K 0.01% 348
2025
Q3
$2.87K Hold
10
﹤0.01% 318
2025
Q2
$2.63K Hold
10
﹤0.01% 319
2025
Q1
$2.33K Sell
10
-3
-23% -$728 ﹤0.01% 382
2024
Q4
$2.98K Buy
+13
New +$2.98K 0.01% 359

Other funds holding LH

Mowery & Schoenfeld Wealth Management's LH Position: Q1 2026 in Review

Mowery & Schoenfeld Wealth Management reduced its Labcorp (LH) stake by 38% in Q1 2026, selling an estimated $1.63K and leaving 10 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #309.

Mowery & Schoenfeld Wealth Management first reported a position in LH in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.01K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Mowery & Schoenfeld Wealth Management held 10 shares of Labcorp worth $2.67K as of Q1 2026.
  • Mowery & Schoenfeld Wealth Management sold 6 Labcorp shares in Q1 2026, an estimated $1.63K.
  • Labcorp made up ﹤0.01% of Mowery & Schoenfeld Wealth Management's portfolio in Q1 2026, its #309 holding.
  • Mowery & Schoenfeld Wealth Management first reported a position in Labcorp in Q4 2024 and has held it in 6 quarters since.
  • Mowery & Schoenfeld Wealth Management's Labcorp position peaked at $4.01K in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.